中国经济网北京12月1日讯 嘉戎技术(301148.SZ)今日复牌，股价一字涨停，创上市以来新高，截至发稿报39.64元，上涨20.01%，总市值 46.18亿元。 嘉戎技术昨晚披露的发行股份及支付现金购买资产并募集配套资金预案显示，上市公司拟通过发行股份及支付现金的方式向厦门溥玉、 楼永通、卿波、柴志国、邓德涛、杭州蓝盈、杭州蓝合等共19名交易对方购买其合计持有的杭州蓝然100%股份，并向厦门溥玉发行股份募 集配套资金不超过100,000万元。上述发行股份及支付现金购买资产和募集配套资金互为前提，共同构成本次交易不可分割的组成部分，其中 任何一项未获得所需的批准或其他原因导致无法付诸实施，则上述两项均不实施。 上市公司控股股东、实际控制人蒋林煜、王如顺、董正军签署了《一致行动人协议之解除协议》，同意将蒋林煜、王如顺、董正军于 2018年3月12日签订的《一致行动人协议》自本次交易交割完成之日起解除，各方不再基于《一致行动人协议》享有任何权利、承担任何义 务；各方确认如本次交易终止，《一致行动人协议》自本次交易终止之日起亦解除，各方基于《一致行动人协议》所享有的所有权利、承担 的所有义务亦终止；在《一致行动人 ...

嘉戎技术（301148）今日早盘"20cm"涨停，公司今日披露非公开发行预案，拟通过发行股份及支付现 金的方式向厦门溥玉、楼永通、卿波、柴志国、邓德涛、杭州蓝盈、杭州蓝合等共19名交易对方购买其 合计持有的杭州蓝然100%股份，并向厦门溥玉发行股份募集配套资金不超过10亿元。本次交易预计构 成重大资产重组。 标的公司以电渗析技术研发与应用为核心，主要从事离子交换膜及膜组件、电渗析相关设备的研发、生 产、销售及技术服务，构建了一条涵盖"膜材料-离子交换膜膜组件-电渗析设备-控制系统-电渗析应用技 术-电渗析应用集成设备"的电渗析产业链，帮助客户以清洁、高效的方式实现特定工业酸碱产品的制 备、工业流体的分离纯化、废水资源化和循环利用、催化电解制备化学品和二氧化碳捕集、封存和使用 （CCUS）等，满足客户生产中绿色低碳生产、物料循环利用及废水清洁处理等差异化需求。 上市公司现有的压力驱动膜技术（如超滤、纳滤、反渗透）与标的公司核心的电驱动膜技术（如电渗 析、双极膜转化）是工业分离纯化的两大核心技术路径，二者具备很强的互补性，在废水资源化和物料 流体分离中分属于核心工艺前后段。本次交易将使上市公司获得电渗析全链条技术 ...

4只A股即将复牌！ 凯众股份拟购买安徽拓盛60%股权 另外，11月27日，上市公司控股股东、实际控制人蒋林煜、王如顺、董正军签署了《一致行动人协议之解除协 议》，同意将蒋林煜、王如顺、董正军于2018年3月12日签订的《一致行动人协议》自本次交易交割完成之日 起解除，各方不再基于《一致行动人协议》享有任何权利、承担任何义务。嘉戎技术称，根据目前的交易方 案，本次交易完成后，厦门溥玉预计将成为上市公司控股股东，胡殿君预计将成为上市公司实际控制人。 据了解，本次交易前，上市公司嘉戎技术以膜分离技术为核心，主营业务为系列特种膜分离材料及组件、膜分 离成套装备、高性能低温真空蒸发装备等产品的研发、生产和销售，以及提供高浓度污废水处理服务、资源循 环回收解决方案等。标的公司杭州蓝然以电渗析技术研发与应用为核心，主要从事离子交换膜及膜组件、电渗 析相关设备的研发、生产、销售及技术服务，构建了一条涵盖"膜材料—离子交换膜 — 膜组件 — 电渗析设备 — 控制系统 — 电渗析应用技术 — 电渗析应用集成设备"的电渗析产业链。 嘉戎技术表示，此次交易将使上市公司获得电渗析全链条技术，实现技术平台的进一步拓展。整合后，上市公 司 ...

Core Viewpoint - The company, 嘉戎技术, plans to acquire 100% of 杭州蓝然 and raise up to 1 billion yuan through a private placement to enhance its technological capabilities and market presence in various sectors [1][3][4]. Group 1: Acquisition Details - 嘉戎技术 intends to purchase 杭州蓝然 through a combination of share issuance and cash payment, with the transaction expected to constitute a major asset restructuring [1][3]. - Following the acquisition, 杭州蓝然 will become a wholly-owned subsidiary, and the investor 厦门溥玉 is anticipated to become the controlling shareholder [1][3]. Group 2: 杭州蓝然 Overview - 杭州蓝然 is a national high-tech enterprise focused on electrodialysis technology, producing ion exchange membranes and related equipment, with applications in various industries including lithium batteries and pharmaceuticals [3][4]. - The company has received multiple awards and holds numerous patents, including 42 invention patents and 63 utility model patents [3][4]. Group 3: Strategic Benefits - The acquisition will allow 嘉戎技术 to build a comprehensive technology matrix, enhancing its ability to provide integrated solutions by combining pressure-driven and electric-driven membrane technologies [4][5]. - This strategic move is expected to facilitate entry into emerging markets such as lithium battery materials and biomedicine, leveraging 杭州蓝然's established customer channels [5].

Core Viewpoint - The company plans to acquire 100% of Hangzhou Lanan Technology Co., Ltd. through a combination of share issuance and cash payment, with the aim of enhancing its technological capabilities and market presence in various industries [2][3]. Group 1: Acquisition Details - The acquisition involves 19 counterparties and aims to raise up to 1 billion yuan through share issuance to Xiamen Puyu Investment Partnership [2]. - Upon completion, Hangzhou Lanan will become a wholly-owned subsidiary, and Xiamen Puyu is expected to become the controlling shareholder [2]. Group 2: Target Company Overview - Hangzhou Lanan is a national high-tech enterprise focused on electrodialysis technology, producing ion exchange membranes and related equipment [3]. - The company has established a comprehensive electrodialysis industry chain and has received multiple national and provincial awards, including the National Science and Technology Progress Award [3]. Group 3: Financial Performance - For the years 2023, 2024, and the first ten months of 2025, Hangzhou Lanan reported revenues of 324 million yuan, 304 million yuan, and 144 million yuan, respectively, with net profits of approximately 70.37 million yuan, 70.78 million yuan, and 13.21 million yuan [4]. Group 4: Strategic Benefits - The acquisition will allow the company to build a comprehensive technology matrix, enhancing its ability to provide integrated solutions by combining pressure-driven and electric-driven membrane technologies [4]. - The integration will enable the company to address industry pain points in lithium extraction and high-concentration wastewater treatment, promoting low-carbon and resource recovery solutions [5]. Group 5: Market Expansion - The company aims to penetrate emerging markets such as lithium battery materials, biomedicine, and carbon capture, leveraging Hangzhou Lanan's established customer channels for business growth [6]. - The acquisition will facilitate the transition from a wastewater treatment service provider to a resource recycling and green technology partner, enhancing customer loyalty and value [6].

Group 1: Business Expansion and Performance - The company achieved overseas business revenue of 26.804 million yuan in 2024, representing a 41.20% increase compared to the same period in 2023 [3] - The overseas market expansion has successfully entered multiple countries, including Europe, Singapore, Brazil, Colombia, Malaysia, and Vietnam [3] - The company plans to enhance its overseas sales and service network by collaborating with local enterprises and understanding market demands [3] Group 2: Technological Applications and Innovations - The company is actively exploring membrane technology applications in emerging sectors, including the new energy industry, to expand its business boundaries [2] - In the circular economy sector, the company has established a presence in the lithium battery industry, focusing on upstream cathode material production processes and associated wastewater treatment [4] - The company is engaged in technical collaborations with leading industry players for projects related to electrolyte recovery, waste acid treatment, and precious metal recovery, with most projects currently in the planning stage [4] Group 3: Strategic Responses to Market Conditions - The impact of Sino-U.S. trade tensions on the company is limited, as the revenue from U.S. operations constitutes a very small percentage of total income [3] - The company has implemented strategic stockpiling and is developing domestic alternatives for raw materials sourced from the U.S. to mitigate potential risks [3] - The company will closely monitor international political and economic changes to adjust its strategies accordingly [3]